Search Results - "Rigault de la Longrais, I.A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer by Lu, Lingeng, Katsaros, Dionyssios, Wiley, Andrew, Rigault de la Longrais, I.A., Puopolo, Manuela, Schwartz, Peter, Yu, Herbert

    Published in Gynecologic oncology (01-12-2006)
    “…The IGF-II gene has four promoters (P1–P4); each initiates promoter-specific transcription. Studies have shown that IGF-II promoters normally active during…”
    Get full text
    Journal Article
  2. 2

    Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer by Katsaros, D., Cho, W., Singal, R., Fracchioli, S., Rigault de la Longrais, I.A., Arisio, R., Massobrio, M., Smith, M., Zheng, W., Glass, J., Yu, H.

    Published in Gynecologic oncology (01-09-2004)
    “…Objective. Methylation of p16 promoter was evaluated in ovarian cancer to determine the role of p16 methylation in ovarian cancer prognosis. Methods. Two…”
    Get full text
    Journal Article
  3. 3

    Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma by Katsaros, D., Oletti, M. V., Rigault de la Longrais, I. A., Ferrero, A., Celano, A., Fracchioli, S., Donadio, M., Passera, R., Cattel, L., Bumma, C.

    Published in Annals of oncology (01-02-2005)
    “…Background: This multicenter phase II study evaluated feasibility, clinical efficacy, toxicity and pharmacokinetics of the combination of pegylated liposomal…”
    Get full text
    Journal Article